From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 743,436 shares, representing 1.28% for KRW 4,990.07 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,830 KRW | -1.33% | -6.76% | -29.69% |
24/01 | Elevance Health Offers Stronger-Than-Expected 2024 Earnings Outlook After Fourth-Quarter Beat | MT |
24/01 | Elevance Health Issues Upbeat 2024 Adjusted. Earnings Outlook After 4Q Revenue Gains | DJ |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.69% | 202M | |
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |
- Stock Market
- Equities
- A099430 Stock
- News Bio Plus Co., Ltd
- Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.